Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY – Get Free Report) rose 0.9% on Thursday . The stock traded as high as $3.41 and last traded at $3.33. Approximately 374,592 shares changed hands during trading, a decline of 35% from the average daily volume of 574,669 shares. The stock had previously closed at $3.30.
Ono Pharmaceutical Price Performance
The business has a fifty day simple moving average of $3.49 and a 200-day simple moving average of $4.12.
About Ono Pharmaceutical
Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.
Featured Stories
- Five stocks we like better than Ono Pharmaceutical
- Options Trading – Understanding Strike Price
- Chipotle’s Slip: A Short-Term Dip or Long-Term Opportunity?
- 3 Small Caps With Big Return Potential
- Why New Tariffs Could Boost These 3 Basic Materials Stocks
- What Makes a Stock a Good Dividend Stock?
- MarketBeat Week in Review – 02/03 – 02/07
Receive News & Ratings for Ono Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ono Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
